Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to better understand how amino acids alter the release of glucagon
and insulin compared to glucose alone in health and disease.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)